WHO’s Global Status Report on Cancer 2026 warns cancer cases could reach 35 million by 2050. Inequities in diagnosis, ...
The World Health Organization tempered optimism about improvements in cancer treatment and said global health care inequities ...
The Alberta Cancer Foundation is investing $35-million to advance cancer clinical trials in Alberta. The amount represents one of the largest investments into clinical trials over a five-year window ...
Considerable cancer disparities persist in the US, according to a recent report published by the American Association for Cancer Research.
Urological tumors, including prostate cancer and urothelial carcinomas, remain major contributors to global cancer morbidity and mortality. Despite recent ...
A UCLA study has identified a hidden Achilles' heel in aggressive small cell cancers that have resisted new treatments for ...
Morning Overview on MSN
A targeted drug won approval for a hard-to-treat form of advanced prostate cancer
Men diagnosed with metastatic hormone-sensitive prostate cancer who carry a specific tumor deficiency now have a targeted ...
Smart PSA boosted targeted screening and found more aggressive prostate cancers in Black men in Chicago trials.
Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...
Development is moving to phase 2 LEGION-100-2a (NCT06533644) across global sites, with planned neoadjuvant prostate studies and expansion concepts in multiple solid tumors. Metastatic ...
The committee that decided to ration prostate cancer screening earlier this year does not contain a single expert on the disease, it has been claimed.
Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth even with stable levels of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results